These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9844877)

  • 1. [Histocompatibility antigens in multiple sclerosis in children].
    Efimenko VN; Evtushenko SK; Khodakovskiĭ AV
    Lik Sprava; 1998 Aug; (6):67-9. PubMed ID: 9844877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatibility (HLA) antigens and multiple sclerosis in Israelis.
    Brautbar C; Amar A; Cohen I; Kahana E; Cohen T; Bloch D; Grosse-Wilde H; Alter M
    Isr J Med Sci; 1982 May; 18(5):631-4. PubMed ID: 7096048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of histocompatibility haplotype HLA-A3-B7 with multiple sclerosis.
    Bertrams HJ; Kuwert EK
    J Immunol; 1976 Nov; 117(5 Pt.2):1906-12. PubMed ID: 993587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA antigen segregation analysis in multiple sclerosis (MS) families.
    Bertrams J; Kuwert E
    Z Immunitatsforsch Immunobiol; 1976 Nov; 152(3):200-8. PubMed ID: 1007375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Histocompatibility antigens in multiple sclerosis patients].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM; Kut'ina RM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(2):7-10. PubMed ID: 7234266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-patterns in patients with multiple sclerosis and type I diabetes mellitus: evidence for possible mutual exclusion of both diseases.
    Lobnig BM; Chantelau E; Vidgrén G; Van Landeghem AA; Kinnunen L; Tuomilehto-Wolf E
    Diabetes Metab; 2002 Jun; 28(3):217-21. PubMed ID: 12149602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe.
    Ballerini C; Guerini FR; Rombolà G; Rosati E; Massacesi L; Ferrante P; Caputo D; Talamanca LF; Naldi P; Liguori M; Alizadeh M; Momigliano-Richiardi P; D'Alfonso S
    J Neuroimmunol; 2004 May; 150(1-2):178-85. PubMed ID: 15081263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined influences of Gm and HLA phenotypes upon multiple sclerosis susceptibility and severity.
    Salier JP; Sesboüé R; Martin-Mondière C; Daveau M; Cesaro P; Cavelier B; Coquerel A; Legrand L; Goust JM; Degos JD
    J Clin Invest; 1986 Aug; 78(2):533-8. PubMed ID: 3461005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple sclerosis and the histocompatibility system].
    Khondkarian OA; Tananov AT; Zavalishin IA; Nevskaia OM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(2):167-71. PubMed ID: 6176089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Multiple sclerosis in Northern-West region of Russia: results of HLA-typing].
    Odinak MM; Bisaga GN; Kalinina NM; Akimov SB; Semilutskaia IB
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(2):40-4. PubMed ID: 10709290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histocompatibility types and measles antibodies in multiple sclerosis.
    Fewster ME; Myers LW; Ellison GW; Walford RL
    J Neurol Sci; 1977 Nov; 34(2):287-96. PubMed ID: 925715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical instrumental and immunological studies of multiple sclerosis in children].
    Evtushenko SK; Efimenko VN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(3):45-9. PubMed ID: 10758648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-D typing in multiple sclerosis: Israelis tested with European homozygous typing cells.
    Brautbar C; Amar A; Cohen N; Oksenberg J; Cohen I; Kahana E; Bloch D; Alter M; Grosse-Wilde H
    Tissue Antigens; 1982 Mar; 19(3):189-97. PubMed ID: 6953617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-immunologic parallels in multiple sclerosis].
    Prokof'ev VF; Konenkov VI; Gribacheva IA; Voronova IA; Doronin BM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):31-4. PubMed ID: 2728717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in multiple sclerosis in Alsace.
    Rumbach L; Tongio MM; Warter JM; Marescaux C; Grange D; Mayer S; Collard M
    Biomed Pharmacother; 1985; 39(7):385-9. PubMed ID: 3830266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA-DRW antigens and multiple sclerosis].
    De Moerloose PH; Jeannet M; Martins-da-Silva B; Werner-Favre C; Rohr J; Gauthier G
    Schweiz Arch Neurol Neurochir Psychiatr; 1978; 123(1):51-61. PubMed ID: 83671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristics of histocompatibility antigens distribution in patients with multiple sclerosis].
    Shiralieva RK; Guseĭnova KA
    Klin Med (Mosk); 1998; 76(1):19-20. PubMed ID: 9532908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple sclerosis--relation between HLA haplotype A25, B18 and disease progression.
    Meyer-Rienecker HJ; Wegener S; Hitzschke B; Richter KV
    Acta Neurol Scand; 1982 Dec; 66(6):709-12. PubMed ID: 6819759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis.
    Kroner A; Grimm A; Johannssen K; Mäurer M; Wiendl H
    Hum Immunol; 2007 May; 68(5):422-5. PubMed ID: 17462509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.